Collegium Pharmaceutical Share Price Today
(NASDAQ: COLL)

Name: Collegium Pharmaceutical Share Price Today (NASDAQ: COLL) - Collegium Pharmaceutical Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Collegium Pharmaceutical share price is $30.93 & ₹2,693.85 as on 5 Feb 2025, 2.30 'hrs' IST

$30.93

▲

-0.27

(-0.87%)

Market is closed - opens 8 PM, 05 Feb 2025

View live Collegium Pharmaceutical share price in Dollar and Rupees. Guide to invest in Collegium Pharmaceutical stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Collegium Pharmaceutical, along with analyst recommendations, forecasts, and comprehensive financials.

Collegium Pharmaceutical share price movements

Today's Low: $30.23
Today's High: $31.03
$30.93
2.26%
Downside
Day's Volatility :2.58%
Upside
0.32%
52 Weeks Low: $28.39
52 Weeks High: $42.29
$30.93
8.21%
Downside
52 Weeks Volatility :32.86%
Upside
26.86%

Collegium Pharmaceutical (COLL) Returns

Period	Collegium Pharmaceutical Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-9.57%	0.5%	0.0%
6 Months	-9.96%	-2.3%	0.0%
1 Year	-6.14%	3.8%	0.0%
3 Years	70.77%	11.4%	-11.7%

Collegium Pharmaceutical (COLL) Key Statistics

in dollars & INR

Previous Close	$31.2
Open	$30.81
Today's High	$31.03
Today's Low	$30.23
Market Capitalization	$1.0B
Today's Volume	$260.4K
52 Week High	$42.2873
52 Week Low	$28.39
Revenue TTM	$599.2M
EBITDA	$365.8M
Earnings Per Share (EPS)	$2.34
PE Ratio	13.73
Profit Margin	14.78%
Quarterly Earnings Growth YOY	-0.49%
Return On Equity TTM	42.89%

How to invest in Collegium Pharmaceutical Stock (COLL) from India?

It is very easy for Indian residents to invest directly in Collegium Pharmaceutical from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Collegium Pharmaceutical stock in both Indian Rupees (INR) and US Dollars (USD). Search for Collegium Pharmaceutical or COLL on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Collegium Pharmaceutical or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Collegium Pharmaceutical shares which would translate to 0.028 fractional shares of Collegium Pharmaceutical as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Collegium Pharmaceutical, in just a few clicks!

Returns in Collegium Pharmaceutical (COLL) for Indian investors in Rupees

The Collegium Pharmaceutical stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Collegium Pharmaceutical investment value today

Current value as on today

₹97,915

Returns

₹2,085

(-2.08%)

Returns from Collegium Pharmaceutical Stock

₹6,949 (-6.95%)

Dollar Returns

₹4,865 (+4.86%)

Indian investors sentiment towards Collegium Pharmaceutical (COLL)

-35%

Period: Jan 5, 2025 to Feb 4, 2025. Change in 30 Days versus previous period

Search interest for Collegium Pharmaceutical Stock from India on INDmoney has decreased by -35% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Collegium Pharmaceutical

BlackRock Inc
17.12%
Eventide Asset Management, LLC
8.17%
Vanguard Group Inc
7.28%
Pacer Advisors, INC.
6.64%
Principal Financial Group Inc
5.41%
Renaissance Technologies Corp
5.14%

Analyst Recommendation on Collegium Pharmaceutical

Buy

75%Buy

25%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Collegium Pharmaceutical(by analysts ranked 0 to 5 stars)

Based on 12 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Collegium Pharmaceutical Stock (COLL)

What analysts predicted

Upside of 39.02%

Target:

$43.00

Current:

$30.93

Insights on Collegium Pharmaceutical Stock (Ticker Symbol: COLL)

Price Movement
In the last 3 years, COLL stock has moved up by 71.9%
Increasing Revenue
Revenue is up for the last 3 quarters, 144.92M → 159.30M (in $), with an average increase of 4.5% per quarter
Decreasing Net Profit
Netprofit is down for the last 4 quarters, 31.94M → 9.33M (in $), with an average decrease of 31.6% per quarter
COLL vs ITCI (1 yr)
In the last 1 year, Intra-cellular Therapies, Inc. has given 89.1% return, outperforming this stock by 94.1%
COLL vs ITCI (3 yr)
In the last 3 years, Intra-cellular Therapies, Inc. has given 161.1% return, outperforming this stock by 89.2%
Price to Sales
ForCOLL every $1 of sales, investors are willing to pay $1.7, whereas for Intra-cellular Therapies, Inc., the investors are paying $20.9 for every $1 of sales.

COLL Collegium Pharmaceutical Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$280.4M	↑ 884.73%
Net Income	$-39.1M	↓ 47.74%
Net Profit Margin	-13.95%	↑ 248.96%

	FY19	Y/Y Change
Revenue	$296.7M	↑ 5.81%
Net Income	$-8.1M	↓ 79.18%
Net Profit Margin	-2.75%	↑ 11.2%

	FY20	Y/Y Change
Revenue	$310.0M	↑ 4.49%
Net Income	$26.8M	↓ 428.33%
Net Profit Margin	8.63%	↑ 11.38%

	FY21	Y/Y Change
Revenue	$276.9M	↓ 10.69%
Net Income	$71.5M	↑ 167.33%
Net Profit Margin	25.83%	↑ 17.2%

	FY22	Y/Y Change
Revenue	$463.9M	↑ 67.56%
Net Income	$-25.0M	↓ 134.96%
Net Profit Margin	-5.39%	↓ 31.22%

	FY23	Y/Y Change
Revenue	$566.8M	↑ 22.17%
Net Income	$48.2M	↓ 292.6%
Net Profit Margin	8.5%	↑ 13.89%

	Q2 FY23	Q/Q Change
Revenue	$135.5M	↓ 6.37%
Net Income	$13.0M	↓ 174.64%
Net Profit Margin	9.6%	↑ 21.64%

	Q3 FY23	Q/Q Change
Revenue	$136.7M	↑ 0.86%
Net Income	$20.6M	↑ 58.64%
Net Profit Margin	15.09%	↑ 5.49%

	Q4 FY23	Q/Q Change
Revenue	$149.7M	↑ 9.54%
Net Income	$31.9M	↑ 54.79%
Net Profit Margin	21.33%	↑ 6.24%

	Q1 FY24	Q/Q Change
Revenue	$144.9M	↓ 3.22%
Net Income	$27.7M	↓ 13.23%
Net Profit Margin	19.12%	↓ 2.21%

	Q2 FY24	Q/Q Change
Revenue	$145.3M	↑ 0.24%
Net Income	$19.6M	↓ 29.25%
Net Profit Margin	13.5%	↓ 5.62%

	Q3 FY24	Q/Q Change
Revenue	$159.3M	↑ 9.65%
Net Income	$9.3M	↓ 52.39%
Net Profit Margin	5.86%	↓ 7.64%

	FY18	Y/Y Change
Profit	$114.7M	↑ 343.32%

	FY19	Y/Y Change
Profit	$103.0M	↓ 10.19%

	FY20	Y/Y Change
Profit	$179.8M	↑ 74.53%

	FY21	Y/Y Change
Profit	$150.6M	↓ 16.25%

	FY22	Y/Y Change
Profit	$209.5M	↑ 39.09%

	FY23	Y/Y Change
Profit	$326.2M	↑ 55.7%

	Q2 FY23	Q/Q Change
Profit	$73.8M	↓ 4.62%

	Q3 FY23	Q/Q Change
Profit	$80.3M	↑ 8.78%

	Q4 FY23	Q/Q Change
Profit	$94.6M	↑ 17.83%

	Q1 FY24	Q/Q Change
Profit	$91.5M	↓ 3.35%

	Q2 FY24	Q/Q Change
Profit	$90.8M	↓ 0.71%

	Q3 FY24	Q/Q Change
Profit	$96.8M	↑ 6.59%

	FY18	Y/Y Change
Operating Cash Flow	$169.4M	↓ 352.75%
Investing Cash Flow	$-24.4M	↑ 2360.0%
Financing Cash Flow	$-117.2M	↓ 450.05%

	FY19	Y/Y Change
Operating Cash Flow	$27.8M	↓ 83.6%
Investing Cash Flow	$-6.4M	↓ 73.56%
Financing Cash Flow	$2.0M	↓ 101.74%

	FY20	Y/Y Change
Operating Cash Flow	$93.9M	↑ 238.13%
Investing Cash Flow	$-373.8M	↑ 5705.72%
Financing Cash Flow	$286.5M	↑ 13935.96%

	FY21	Y/Y Change
Operating Cash Flow	$103.6M	↑ 10.24%
Investing Cash Flow	$-1.9M	↓ 99.48%
Financing Cash Flow	$-89.3M	↓ 131.17%

	FY22	Y/Y Change
Operating Cash Flow	$124.2M	↑ 19.96%
Investing Cash Flow	$-573.7M	↑ 29410.85%
Financing Cash Flow	$436.7M	↓ 589.04%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$99.7M	↑ 260.38%
Investing Cash Flow	$-41.7M	↑ 23602.84%
Financing Cash Flow	$-45.2M	↓ 166.23%

Collegium Pharmaceutical Technicals Summary

Sell

Neutral

Buy

Collegium Pharmaceutical is currently in a neutral trading position according to technical analysis indicators.

Collegium Pharmaceutical (COLL) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Collegium Pharmaceutical Inc	9.01%	-9.96%	-6.14%	70.77%	22.59%
Intra-cellular Therapies, Inc.	55.53%	72.74%	81.47%	149.54%	495.46%
Haleon Plc Spon Ads	0.32%	-1.35%	13.13%	27.94%	27.94%
Zoetis Inc.	3.64%	-6.94%	-12.34%	-14.17%	23.79%
Neurocrine Biosciences Inc.	9.68%	4.14%	4.99%	85.26%	44.35%
Viatris Inc.	-7.62%	-2.82%	-7.15%	-27.65%	-32.44%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Collegium Pharmaceutical Inc	13.73	13.73	0.0	6.18	0.43	0.1	NA	7.27
Intra-cellular Therapies, Inc.	NA	NA	0.0	-0.71	-0.1	-0.07	NA	10.8
Haleon Plc Spon Ads	28.7	28.7	1.68	0.36	0.07	0.04	0.02	1.82
Zoetis Inc.	32.18	32.18	2.66	5.89	0.47	0.15	0.01	11.59
Neurocrine Biosciences Inc.	40.03	40.03	0.35	6.59	0.16	0.12	NA	26.87
Viatris Inc.	224.4	NA	0.07	2.68	-0.04	0.02	0.04	16.58

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Collegium Pharmaceutical Inc	Buy	$1.0B	22.59%	13.73	14.78%
Intra-cellular Therapies, Inc.	Buy	$13.5B	495.46%	NA	-14.07%
Haleon Plc Spon Ads	Buy	$42.8B	27.94%	28.7	10.75%
Zoetis Inc.	Buy	$77.1B	23.79%	32.18	26.55%
Neurocrine Biosciences Inc.	Buy	$15.2B	44.35%	40.03	17.21%
Viatris Inc.	Hold	$13.5B	-32.44%	224.4	-5.87%

About Collegium Pharmaceutical

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, and oral formulation of oxycodone for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; Belbuca, a buccal film that contains buprenorphine; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.

Organization	Collegium Pharmaceutical
Employees	197
CEO	Mr. Michael Thomas Heffernan B.S. Pharm, R.Ph.
Industry	Health Technology

Management People of Collegium Pharmaceutical

Name	Title
Mr. Michael Thomas Heffernan B.S. Pharm, R.Ph.	Co-Founder & Chairman
Ms. Colleen Tupper	Executive VP & CFO
Ms. Shirley R. Kuhlmann J.D.	Executive VP, General Counsel, Chief Administrative Officer & Secretary
Mr. Scott Dreyer	Executive VP & Chief Commercial Officer
Dr. Thomas B. Smith FAAFP, M.D.	Executive VP & Chief Medical Officer
Mr. Vikram Karnani	CEO, President & Director
Mr. Scott Sudduth	Head of Technical Operations

Important FAQs about investing in COLL Stock from India :

What is Collegium Pharmaceutical share price today?

Collegium Pharmaceutical share price today stands at $30.93, Open: $30.81 ; Previous Close: $31.20 ; High: $31.03 ; Low: $30.23 ; 52 Week High: $42.29 ; 52 Week Low: $28.39.

The stock opens at $30.81, after a previous close of $31.20. The stock reached a daily high of $31.03 and a low of $30.23, with a 52-week high of $42.29 and a 52-week low of $28.39.

Can Indians buy Collegium Pharmaceutical shares?

Yes, Indians can invest in the Collegium Pharmaceutical (COLL) from India.

With INDmoney, you can buy Collegium Pharmaceutical at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Collegium Pharmaceutical at zero transaction cost.

How can I buy Collegium Pharmaceutical shares from India?

It is very easy to buy Collegium Pharmaceutical from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Collegium Pharmaceutical (COLL) be purchased?

Yes, you can buy fractional shares of Collegium Pharmaceutical with INDmoney app.

What are the documents required to start investing in Collegium Pharmaceutical stocks?

To start investing in Collegium Pharmaceutical, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.